Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017

M. Krone, S. Gray, R. Abad, A. Skoczyńska, P. Stefanelli, A. van der Ende, G. Tzanakaki, P. Mölling, M. João Simões, P. Křížová, S. Emonet, DA. Caugant, M. Toropainen, J. Vazquez, I. Waśko, MJ. Knol, S. Jacobsson, C. Rodrigues Bettencourt, M....

. 2019 ; 24 (14) : . [pub] -

Jazyk angličtina Země Švédsko

Typ dokumentu časopisecké články, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc20022803

Grantová podpora
Wellcome Trust - United Kingdom

BackgroundThe total incidence of invasive meningococcal disease (IMD) in Europe has been declining in recent years; however, a rising incidence due to serogroup W (MenW), predominantly sequence type 11 (ST-11), clonal complex 11 (cc11), was reported in some European countries.AimThe aim of this study was to compile the most recent laboratory surveillance data on MenW IMD from several European countries to assess recent trends in Europe.MethodsIn this observational, retrospective study, IMD surveillance data collected from 2013-17 by national reference laboratories and surveillance units from 13 European countries were analysed using descriptive statistics.ResultsThe overall incidence of IMD has been stable during the study period. Incidence of MenW IMD per 100,000 population (2013: 0.03; 2014: 0.05; 2015: 0.08; 2016: 0.11; 2017: 0.11) and the proportion of this serogroup among all invasive cases (2013: 5% (116/2,216); 2014: 9% (161/1,761); 2015: 13% (271/2,074); 2016: 17% (388/2,222); 2017: 19% (393/2,112)) continuously increased. The most affected countries were England, the Netherlands, Switzerland and Sweden. MenW was more frequent in older age groups (≥ 45 years), while the proportion in children (< 15 years) was lower than in other age groups. Of the culture-confirmed MenW IMD cases, 80% (615/767) were caused by hypervirulent cc11.ConclusionDuring the years 2013-17, an increase in MenW IMD, mainly caused by MenW cc11, was observed in the majority of European countries. Given the unpredictable nature of meningococcal spread and the epidemiological potential of cc11, European countries may consider preventive strategies adapted to their contexts.

Department of Epidemiology and Surveillance National Institute for Public Health and the Environment Bilthoven the Netherlands

Department of Health Security National Institute for Health and Welfare Helsinki Finland

Department of Infectious Diseases National Institute of Health Dr Ricardo Jorge Lisboa Portugal

Dept of Infectious Diseases Istituto Superiore di Sanità Rome Italy

Division for Infection Control and Environmental Health Norwegian Institute of Public Health Oslo Norway

Division of Communicable Diseases Federal Office of Public Health Bern Switzerland

Division of Infectious Diseases Geneva University Hospitals Geneva Switzerland

Institute for Hygiene and Microbiology University of Würzburg Würzburg Germany

Meningococcal Reference Unit Public Health England Manchester United Kingdom

National Meningitis Reference Laboratory National School of Public Health Athens Greece

National Reference Centre for Bacterial Meningitis National Medicines Institute Warsaw Poland

National Reference Laboratory for Meningococcal Infections National Institute of Public Health Prague Czech Republic

National Reference Laboratory for Neisseria meningitidis Department of Laboratory Medicine Faculty of Medicine and Health Örebro University Örebro Sweden

Spanish Reference Laboratory for Meningococci National Centre for Microbiology Instituto de Salud Carlos 3 Madrid Spain

The Netherlands Reference Laboratory for Bacterial Meningitis Department of Medical Microbiology Academic Medical Center Amsterdam Netherlands

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20022803
003      
CZ-PrNML
005      
20201214124826.0
007      
ta
008      
201125s2019 sw f 000 0|eng||
009      
AR
024    7_
$a 10.2807/1560-7917.ES.2019.24.14.1800245 $2 doi
035    __
$a (PubMed)30968827
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Krone, Manuel $u Institute for Hygiene and Microbiology, University of Würzburg, Würzburg, Germany.
245    10
$a Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017 / $c M. Krone, S. Gray, R. Abad, A. Skoczyńska, P. Stefanelli, A. van der Ende, G. Tzanakaki, P. Mölling, M. João Simões, P. Křížová, S. Emonet, DA. Caugant, M. Toropainen, J. Vazquez, I. Waśko, MJ. Knol, S. Jacobsson, C. Rodrigues Bettencourt, M. Musilek, R. Born, U. Vogel, R. Borrow,
520    9_
$a BackgroundThe total incidence of invasive meningococcal disease (IMD) in Europe has been declining in recent years; however, a rising incidence due to serogroup W (MenW), predominantly sequence type 11 (ST-11), clonal complex 11 (cc11), was reported in some European countries.AimThe aim of this study was to compile the most recent laboratory surveillance data on MenW IMD from several European countries to assess recent trends in Europe.MethodsIn this observational, retrospective study, IMD surveillance data collected from 2013-17 by national reference laboratories and surveillance units from 13 European countries were analysed using descriptive statistics.ResultsThe overall incidence of IMD has been stable during the study period. Incidence of MenW IMD per 100,000 population (2013: 0.03; 2014: 0.05; 2015: 0.08; 2016: 0.11; 2017: 0.11) and the proportion of this serogroup among all invasive cases (2013: 5% (116/2,216); 2014: 9% (161/1,761); 2015: 13% (271/2,074); 2016: 17% (388/2,222); 2017: 19% (393/2,112)) continuously increased. The most affected countries were England, the Netherlands, Switzerland and Sweden. MenW was more frequent in older age groups (≥ 45 years), while the proportion in children (< 15 years) was lower than in other age groups. Of the culture-confirmed MenW IMD cases, 80% (615/767) were caused by hypervirulent cc11.ConclusionDuring the years 2013-17, an increase in MenW IMD, mainly caused by MenW cc11, was observed in the majority of European countries. Given the unpredictable nature of meningococcal spread and the epidemiological potential of cc11, European countries may consider preventive strategies adapted to their contexts.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a věkové rozložení $7 D017677
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a dítě $7 D002648
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a meningokokové infekce $x diagnóza $x epidemiologie $7 D008589
650    _2
$a lidé středního věku $7 D008875
650    _2
$a multilokusová sekvenční typizace $7 D058885
650    _2
$a Neisseria meningitidis $x klasifikace $x genetika $x izolace a purifikace $7 D009345
650    _2
$a polymerázová řetězová reakce $7 D016133
650    _2
$a surveillance populace $x metody $7 D011159
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a séroskupina $7 D065288
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Gray, Steve $u Meningococcal Reference Unit, Public Health England, Manchester, United Kingdom.
700    1_
$a Abad, Raquel $u Spanish Reference Laboratory for Meningococci, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
700    1_
$a Skoczyńska, Anna $u National Reference Centre for Bacterial Meningitis, National Medicines Institute, Warsaw, Poland.
700    1_
$a Stefanelli, Paola $u Dept. of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
700    1_
$a van der Ende, Arie $u The Netherlands Reference Laboratory for Bacterial Meningitis, Department of Medical Microbiology, Academic Medical Center, Amsterdam, Netherlands.
700    1_
$a Tzanakaki, Georgina $u National Meningitis Reference Laboratory, National School of Public Health, Athens, Greece.
700    1_
$a Mölling, Paula $u National Reference Laboratory for Neisseria meningitidis, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
700    1_
$a João Simões, Maria $u Department of Infectious Diseases, National Institute of Health Dr. Ricardo Jorge, Lisboa, Portugal.
700    1_
$a Křížová, Pavla $u National Reference Laboratory for Meningococcal Infections, National Institute of Public Health, Prague, Czech Republic.
700    1_
$a Emonet, Stéphane $u Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
700    1_
$a Caugant, Dominique A $u Division for Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
700    1_
$a Toropainen, Maija $u Department of Health Security, National Institute for Health and Welfare (THL), Helsinki, Finland.
700    1_
$a Vazquez, Julio $u Spanish Reference Laboratory for Meningococci, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
700    1_
$a Waśko, Izabela $u National Reference Centre for Bacterial Meningitis, National Medicines Institute, Warsaw, Poland.
700    1_
$a Knol, Mirjam J $u Department of Epidemiology and Surveillance, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
700    1_
$a Jacobsson, Susanne $u National Reference Laboratory for Neisseria meningitidis, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
700    1_
$a Rodrigues Bettencourt, Célia $u Department of Infectious Diseases, National Institute of Health Dr. Ricardo Jorge, Lisboa, Portugal.
700    1_
$a Musilek, Martin $u National Reference Laboratory for Meningococcal Infections, National Institute of Public Health, Prague, Czech Republic.
700    1_
$a Born, Rita $u Division of Communicable Diseases, Federal Office of Public Health (FOPH), Bern, Switzerland.
700    1_
$a Vogel, Ulrich $u Institute for Hygiene and Microbiology, University of Würzburg, Würzburg, Germany.
700    1_
$a Borrow, Ray $u Meningococcal Reference Unit, Public Health England, Manchester, United Kingdom.
773    0_
$w MED00174364 $t Euro surveillance : bulletin Europeen sur les maladies transmissibles European communicable disease bulletin $x 1560-7917 $g Roč. 24, č. 14 (2019)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30968827 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214124826 $b ABA008
999    __
$a ok $b bmc $g 1595122 $s 1113479
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 24 $c 14 $e - $i 1560-7917 $m Euro surveillance $n Euro Surveill $x MED00174364
GRA    __
$p Wellcome Trust $2 United Kingdom
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace